Indonesia’s Food and Drug Monitoring Agency (BPOM) has initiated regulatory and collaborative measures to safeguard the supply of pharmaceutical raw materials, responding to escalating disruptions in the Strait of Hormuz.
The agency’s move highlights the growing vulnerability of global supply chains to geopolitical instability in key maritime chokepoints.
The intervention comes as tensions in the Persian Gulf intensify, threatening the flow of critical goods.
While the Strait of Hormuz remains a vital artery for global energy and trade, recent attacks on commercial vessels have forced the International Maritime Organization (IMO) to suspend its evacuation and escort initiatives.
Oman has attempted to mitigate some risks by establishing a temporary maritime corridor, but the overall security environment remains precarious.
For pharmaceutical manufacturers, the disruption poses a direct threat to production continuity.